To further clarify the anti-tumor effects of Fasudil in combination with gefitinib, we examined the effects of this drug combination on EGFR/PI3K/AKT signaling pathways in HCC827GR and H1975 cells (Figure 2G). Here, PIK3CA is linked to neoplasm.